• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗米芬柠檬酸盐联合重组促卵泡激素和重组促黄体生成素刺激与促性腺激素释放激素激动剂方案刺激的比较:一项前瞻性随机研究。

Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.

作者信息

Weigert Monika, Krischker Ursula, Pöhl Michaela, Poschalko Gunda, Kindermann Christoph, Feichtinger Wilfried

机构信息

Institut für Sterilitätsbetreuung, Vienna, Austria

出版信息

Fertil Steril. 2002 Jul;78(1):34-9. doi: 10.1016/s0015-0282(02)03174-6.

DOI:10.1016/s0015-0282(02)03174-6
PMID:12095487
Abstract

OBJECTIVE

To compare IVF-ET outcome with a new stimulation protocol using clomiphene citrate (CC) with recombinant FSH and LH to stimulation with the standard long GnRH-a protocol.

DESIGN

Prospective randomized study.

SETTING

Outpatient infertility clinic in Vienna, Austria.

PATIENT(S): Two hundred ninety-four infertile women undergoing IVF-ET; 154 IVF cycles stimulated with CC + recombinant FSH + recombinant LH (group A) and 140 cycles with long GnRH-a suppression + recombinant FSH (group B).

INTERVENTION(S): Controlled ovarian hyperstimulation, egg retrieval, and ET.

MAIN OUTCOME MEASURE(S): Cycle parameters (number of oocytes, fertilization, number of embryos) and outcome (pregnancy rate, cancellation rate, ovarian hyperstimulation syndrome [OHSS]).

RESULT(S): Pregnancy rate per ET was 42.9% (implantation rate, 21.3%) in group A and 36.6% (17.4%) in group B. Cancellation rates were similar. The OHSS occurred in four cases (3%) in group A and 12 cases (10%) in group B.

CONCLUSION(S): Stimulation with CC + recombinant FSH + recombinant LH leads to comparable pregnancy rates vs. the long protocol. With this new stimulation, less gonadotropins are used and there is less need for monitoring (lower cost for patient and clinic). The risk of OHSS is reduced as well. Therefore, this protocol should be regarded as the first-line treatment.

摘要

目的

比较使用枸橼酸氯米芬(CC)联合重组促卵泡生成素(FSH)和促黄体生成素(LH)的新刺激方案与标准长方案促性腺激素释放激素激动剂(GnRH-a)刺激方案进行体外受精-胚胎移植(IVF-ET)的结局。

设计

前瞻性随机研究。

地点

奥地利维也纳的门诊不孕症诊所。

患者

294名接受IVF-ET的不孕女性;154个IVF周期采用CC+重组FSH+重组LH刺激(A组),140个周期采用长方案GnRH-a抑制+重组FSH刺激(B组)。

干预措施

控制性卵巢过度刺激、取卵和胚胎移植。

主要观察指标

周期参数(卵母细胞数量、受精情况、胚胎数量)和结局(妊娠率、取消率、卵巢过度刺激综合征[OHSS])。

结果

A组每次胚胎移植的妊娠率为42.9%(着床率为21.3%),B组为36.6%(17.4%)。取消率相似。A组有4例(3%)发生OHSS,B组有12例(10%)发生OHSS。

结论

CC+重组FSH+重组LH刺激方案与长方案相比,妊娠率相当。采用这种新的刺激方案,促性腺激素用量减少,监测需求降低(患者和诊所成本降低)。OHSS风险也降低了。因此,该方案应被视为一线治疗方案。

相似文献

1
Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.克罗米芬柠檬酸盐联合重组促卵泡激素和重组促黄体生成素刺激与促性腺激素释放激素激动剂方案刺激的比较:一项前瞻性随机研究。
Fertil Steril. 2002 Jul;78(1):34-9. doi: 10.1016/s0015-0282(02)03174-6.
2
Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.重组卵泡刺激素和重组促黄体生成素联合 GnRH 拮抗剂方案与单独使用重组卵泡刺激素方案在年龄≥35 岁患者卵巢刺激中的随机对照研究。
Hum Reprod. 2015 May;30(5):1188-95. doi: 10.1093/humrep/dev038. Epub 2015 Mar 3.
3
[Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].国产高纯度尿促卵泡素对控制性卵巢刺激中体外受精-胚胎移植结局的影响
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):838-42.
4
Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.使用枸橼酸氯米芬和口服避孕药预处理抑制促黄体生成素的微刺激体外受精。
Fertil Steril. 2000 Mar;73(3):587-90. doi: 10.1016/s0015-0282(99)00584-1.
5
Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.对于体外受精结局不佳而原因不明的患者,采用小剂量枸橼酸氯米酚进行温和刺激方案可以获得更多的卵子,从而获得最佳的累积妊娠率。
J Ovarian Res. 2018 May 4;11(1):37. doi: 10.1186/s13048-018-0408-x.
6
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.两种卵巢刺激方案与促性腺激素释放激素(GnRH)拮抗剂联合治疗用于体外受精的随机比较,这两种方案分别是在周期第2天或第5天开始使用重组促卵泡激素并与标准长效GnRH激动剂方案进行对比。
J Clin Endocrinol Metab. 2003 Jan;88(1):166-73. doi: 10.1210/jc.2002-020788.
7
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.在接受体外受精的高危患者中,促性腺激素释放激素(GnRH)激动剂与GnRH拮抗剂联合治疗后用于诱导卵母细胞成熟可预防卵巢过度刺激综合征的风险:一项前瞻性随机对照研究。
Fertil Steril. 2008 Jan;89(1):84-91. doi: 10.1016/j.fertnstert.2007.02.002. Epub 2007 Apr 26.
8
Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early vs. mid-follicular LH exposure: a prospective, randomized, controlled study.早卵泡期与中卵泡期 LH 暴露后证实卵巢低反应患者体外受精结局:一项前瞻性、随机、对照研究。
J Assist Reprod Genet. 2012 Sep;29(9):869-75. doi: 10.1007/s10815-012-9804-0. Epub 2012 May 29.
9
A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.一种新型的促排卵方案,即延迟给予促性腺激素释放激素拮抗剂,联合大剂量重组促卵泡生成素和枸橼酸氯米芬,用于卵巢低反应者和35岁以上女性。
Fertil Steril. 2004 Jun;81(6):1572-7. doi: 10.1016/j.fertnstert.2004.01.022.
10
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.促性腺激素释放激素(GnRH)拮抗剂方案与GnRH激动剂方案中严重卵巢过度刺激综合征的风险:一项纳入1050个首次体外受精/卵胞浆内单精子注射周期的随机对照试验
Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.

引用本文的文献

1
Combination of Continuous Use of Oral Clomiphene Citrate with Injectable Gonadotropins for Ovarian Stimulation: A Single-Center Study.口服枸橼酸氯米芬持续使用联合注射用促性腺激素用于卵巢刺激:一项单中心研究
Life (Basel). 2025 Aug 4;15(8):1235. doi: 10.3390/life15081235.
2
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.辅助生殖的控制性卵巢刺激方案:一项网状荟萃分析。
Cochrane Database Syst Rev. 2025 Jul 1;7(7):CD012586. doi: 10.1002/14651858.CD012586.pub2.
3
Prednisolone at a therapeutic dose is not detrimental to mouse oocyte competence.
治疗剂量的泼尼松龙对小鼠卵母细胞的能力没有损害。
JBRA Assist Reprod. 2025 Mar 13;29(2):289-97. doi: 10.5935/1518-0557.20240108.
4
Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis.轻度与常规卵巢刺激方案在卵巢低反应、正常反应和高反应人群中行体外受精的比较:一项系统评价和荟萃分析。
Hum Reprod Update. 2021 Feb 19;27(2):229-253. doi: 10.1093/humupd/dmaa035.
5
The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review.《用于医学辅助生殖的原创重组人卵泡刺激素阿尔法(果纳芬)引发的卵巢过度刺激综合征和血栓栓塞的频率:一项系统评价》。
Adv Ther. 2020 Dec;37(12):4831-4847. doi: 10.1007/s12325-020-01512-w. Epub 2020 Oct 15.
6
Mild stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist and its influence on serum estradiol level and pregnancy rate.枸橼酸氯米芬联合重组促卵泡激素及促性腺激素释放激素拮抗剂的轻度刺激及其对血清雌二醇水平和妊娠率的影响。
Reprod Med Biol. 2008 Apr 17;7(2):85-89. doi: 10.1111/j.1447-0578.2008.00204.x. eCollection 2008 Jun.
7
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.口服药物,包括枸橼酸氯米芬或芳香化酶抑制剂与促性腺激素联合用于接受体外受精的女性的控制性卵巢刺激。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3.
8
The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer.血清雌二醇水平与克罗米芬/人绝经期促性腺激素卵巢刺激用于体外受精和胚胎移植结局的相关性
Reprod Biol Endocrinol. 2015 Oct 6;13:114. doi: 10.1186/s12958-015-0109-x.
9
Comparison of different stimulation protocols used in in vitro fertilization: a review.不同体外受精刺激方案的比较:综述。
Ann Transl Med. 2015 Jun;3(10):137. doi: 10.3978/j.issn.2305-5839.2015.04.09.
10
Low-cost in vitro fertilization: current insights.低成本体外受精:当前的见解。
Int J Womens Health. 2014 Aug 21;6:817-27. doi: 10.2147/IJWH.S51288. eCollection 2014.